in accordance with the present invention , a high intensity radiopaque contrast agent is disclosed . the agent may be coated on or incorporated within bulk material which may then be subsequently utilized to fabricate a radiopaque medical device . primary effects through chemistry include higher radiopaque concentrations per unit weight of the radiopaque element or agent . secondary effects include selective placement of the radiopaque elements which may further enhance the radiopacity of the device with reduced requirements of the radiopaque agent . such a radiopaque contrast agent may be produced in various forms such as a dendrimer and / or incorporated as the end groups of polymeric chain . in addition one can incorporate biological and / or pharmaceutical agents in combination with the present invention .